<html style="overflow-y: hidden;">
<head>
	<title></title>
</head>
<body style="height: auto; min-height: auto;"><img alt="Livongo-Logo" src="https://livongohealth2ndorg--c.na63.content.force.com/file-asset-public/LivongoLogo?oid=00D4600000180Lw" style="max-width: 1219.8px" title="Livongo-Logo" /><br />
<br />
<span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="line-height: 107%;">{{{Recipient.FirstName}}},</span></span></span><br />
<br />
<span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="color:black">I&rsquo;m excited to share with you the announcement that Livongo </span>has been selected<span style="color:red"> </span><span style="color:black">as the only preferred vendor on Express Scripts industry-first Digital Health Formulary.<span style="background:white"> The new formulary will provide participating employers and health plans the ability to easily integrate Livongo&rsquo;s diabetes, hypertension, and diabetes prevention programs, into their pharmacy benefit.</span></span></span></span><br />
<span style="font-size:12pt"><span style="font-family:Calibri,sans-serif">&nbsp;</span></span><br />
<span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="background:white"><span style="color:black">The Livongo and Express Scripts partnership began in October 2015 and after a thorough assessment of the digital health landscape, ESI selected Livongo as the only preferred vendor. </span></span><br />
&nbsp;</span></span><br />
<span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="line-height: 107%;">A 2019 study by Express Scripts</span></span></span><span id="docs-internal-guid-0c2c73d2-7fff-dce9-8996-cf4b134f4394"><span style="font-size: 12pt; font-family: Calibri, sans-serif; color: rgb(149, 79, 114); font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;"><span style="font-size:0.6em;vertical-align:super;">[i]<span style="background-color: rgb(255, 255, 255);"> </span></span></span></span><span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;">, demonstrates the success and positive impact of our four year partnership both clinically and financially.&nbsp; People actively using Livongo between 3 and 12 months had a range of 5.0 percent to 6.4 percent higher medication adherence, respectively, compared to matched controls.&nbsp;</span></span><br />
<br />
<!--StartFragment--><span style="font-size: 14px;"><span style="font-family:Arial,Helvetica,sans-serif;">The </span></span><span id="docs-internal-guid-0c2c73d2-7fff-dce9-8996-cf4b134f4394"><span style="font-size: 12pt; font-family: Calibri, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;">AMCP</span></span><!--EndFragment-->&nbsp;<span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;">poster<span style="color:black"> is available for download </span></span></span><a href="https://pages.livongo.com/rs/974-XEZ-058/images/AMCP%20Impact%20of%20Diabetes%20Remote%20Monitoring%20Program%20ESI%202019.pdf"><span style="color:#3333cc;"><span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;">here</span></span></span></a> <span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="color:black"> and more information can be found in&nbsp;</span></span></span><a href="https://ir.livongo.com/news-releases/news-release-details/livongo-earns-preferred-status-new-express-scripts-digital"><span style="color:#3333cc;"><span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;">Livongo&#39;s press release</span></span></span></a> <span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="color:black"> or </span></span></span><a href="https://www.express-scripts.com/corporate/articles/express-scripts-improves-patient-access-digital-health-solutions"><span style="color:#3333cc;"><span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;">ESI&#39;s press release</span></span></span></a><span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="color:black">.<br />
<br />
We would welcome the chance to discuss your population and this opportunity to empower individuals with chronic conditions to live better and healthier lives.&nbsp;&nbsp;</span>I can find 30 minutes for us over the next couple of weeks if that works for your schedule?</span></span><br />
<span style="font-size:12pt"><span style="font-family:Calibri,sans-serif">&nbsp;</span></span><br />
<span style="font-size:14px;"><span style="font-family:Arial,Helvetica,sans-serif;"><span style="color:black">Best,</span><br />
<br />
{{{Sender.FirstName}}}<br />
<br />
{{{Sender.Signature}}}</span></span>
<div align="center" style="text-align:center">
<hr align="center" size="1" width="100%" /></div>
<span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><sup><span style="font-size:7.0pt"><span style="color:#954f72">[i]</span></span></sup><span style="color:black"> Kiraat D. Munshi, PhD; Caroline A. Swift, PhD; Callie S. Carter, PharmD; Rochelle R. Henderson, PhD. Impact of a diabetes remote monitoring program. 2019.</span></span></span><br />
<br />
&nbsp;</body>
</html>